Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction

Journal of Medical Virology

Volumn 50, Issue 1, 1996, Pages 97-103

  Dawson, George J ^a   Schlauder, George G ^a   Pilot Matias, Tami J ^a   Thiele, Dwain ^b   Leary, Thomas P ^a   Murphy, Paul ^c   Rosenblatt, Jon E ^c   Simons, John N ^a   Martinson, Francis E A ^d   Gutierrez, Robin A ^a   Lentino, Joseph R ^e   Pachucki, Constance ^e   Muerhoff, A Scott ^a   Widell, Anders ^f   Tegtmeier, Gary ^g   Desai, Suresh ^a   Mushahwar, Isa K ^a  

^a ABBOTT LABORATORIES   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c MAYO CLINIC   (United States)

^d IL   (United States)

^e HINES VA HOSPITAL   (United States)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g Division of New York Blood Center Enterprises   (United States)

Author keywords

GBV C; HCV; Hepatitis

Indexed keywords

ARTICLE; BLOOD DONOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEPATITIS; HEPATITIS G VIRUS; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION;

FLAVIVIRIDAE; HEPATITIS, VIRAL, HUMAN; HUMANS; POLYMERASE CHAIN REACTION; RNA, VIRAL; VIREMIA; VIRUS LATENCY;

GB VIRUS C/HEPATITIS G VIRUS; HEPATITIS C VIRUS; HEPATITIS GB VIRUS B; NON-A, NON-B HEPATITIS VIRUS;

EID: 10244267675     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199609)50:1<97::AID-JMV16>3.0.CO;2-V     Document Type: Article

References (32)

1. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Mees EL, Beach MJ (1992): The natural history of community acquired hepatitis C in the United States. New England Journal of Medicine 327:1899-1905.
2. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989): Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
3. Dawson GJ, Chau KH, Cabal CM, Yarbough PO, Reyes GR, Mushahwar IK (1992): Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM class antibodies utilizing recombinant proteins and synthetic peptides. Journal of Virological Methods 38:175-186.
4. Deinhardt F, Holmes AW, Capps RB, Popper H (1967): Studies on the transmission of disease of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passage and description of liver lesions. Journal of Experimental Medicine 125:673-687.
5. Devare SG, Shatzman A, Robbins KC, Rosenberg M, Aaronson SA (1984): Expression of the PDGF-related transforming protein of simian sarcoma virus in E. coli. Cell 36:43-49.
6. Fagan EA, Ellis D, Tovey G, Lloyd G, Smith HM, Portmann B, Tan K-C, Zuckerman AJ, Williams R (1992): Toga virus like particles in fulminant sporadic non-A, non-B hepatitis after transplantation. Journal of Medical Virology 38:71-77.
7. Feucht H-H, Zollner B, Polywka S, Laufs R (1996): Vertical Transmission of hepatitis G. Lancet 347:615-616.
8. Holland JJ (1996): Evolving virus plaques. Proceedins of the National Academy of Sciences USA 93:545-546.
9. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias, Erker JC, Chalmers ML, Schlauder Dawson GJ, Desai SM, Mushahwar IK (1996a): Sequence and genomic organization of GBV-C: A novel member of the Flaviviridae associated with human A-E hepatitis. Journal of Medical Virology 48:60-67.
10. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK (1996b): Consensus oligonucleotide primers for the detection of GB virus C in human crytopgenic hepatitis. Journal of Virological Methods 56:119-121.
11. Lentino JR, Pachucki CT, Schaaff DM, Schaefer MR, Holzer TJ, Heynen C, Dawson G, Dorus W (1991): Seroprevalence of HTLV I/II and HIV-1 among male intravenous drug abusers in Chicago. Journal of Acquired Immunodeficiency Syndrome 4:901-909.
12. Linnen J, Wages J, Zhang-Keck Z-Y, et al. (1996): Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271:505-509.
13. Marcellin P, Martinot-Peignoux M, Gabriel F, Branger M, Deggot C, Elias A, Xu LZ, Larzul D, Erliner S, Benhamou JP (1993): Chronic non-A non-B, non-C hepatitis among blood donors assessed with HCV third generation tests and polymerase chain reaction. Journal of Hepatology 19:167-170.
14. Martinson FEA, Weigle KA, Mushahwar IK, Weber DJ, Royce R, Lemon SM (1996): Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children. Journal of Medical Virology 48:278-283.
15. Muerhoff AS, Leary TP, Simons NS, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK (1995): Genomic organization of GBV-A and GBV-B: Two new members of the flaviviridae associated with GB-agent hepatitis. Journal of Virology 69:5622-5630.
16. Muerhoff AS, Simons JN, Leary TP, Erker JC, Chalmers ML, Pilot-Matias TJ, Dawson GJ, Desai SM, Mushahwar IK (1996a): Sequence heterogeneity within the 5′-terminal region of the hepatitis GB virus C genome and evidence for genotypes. Journal of Hepatology 25:379-384.
17. Muerhoff AS, Simons JN, Erker JC, Desai SM, Mushahwar IK (1996b): Identification of conserved nucleotide sequences within the GB virus C 5′-untranslated region: Design of PCR primers for detection of viral RNA. Journal of Virological Methods (in press).
18. Nubling CM, Lower J (1996): GB-C genomes in a high-risk group, in plasma pools and in intravenous immunoglobulin. Lancet 347:68.
19. Peters T, Schlauer HJ, Preisler S, Kopp B, Berthold H, Gerok W, Rasenack J (1993): Frequency of hepatitis C in acute posttransfusion hepatitis after open-heart surgery: A prospective study in 1,476 patients. Journal of Medical Virology 39:139-145.
20. Phillips MJ, Blendis LM, Poucell S, et al. (1991): Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course and paramyxoviral features. New England Journal of Medicine 324:455-460.
21. Pilot-Matias TJ, Muerhoff AS, Simons JN, Leary TP, Buijk SL, Chalmers ML, Erker JC, Dawson GJ, Desai SM, Mushahwar IK (1996): Identification of antigenic regions in the GB hepatitis viruses GBV-A GBV-B and GBV-C. Journal of Medical Virology 48:329-338.
22. Reyes GR, Purdy MA, Kim JP, Luk K-C, Young LM, Fry KE, et al. (1990): Isolation of cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247:1336-1339.
23. Schlauder GG, Dawson GJ, Simons JN, Pilot-Matias TJ, Gutierrez RA, Heynen CA, Knigge MF, Kurpiewski GS, Buijk SL, Leary TP, Muerhoff AS, Desai SM, Mushahwar IK (1995a): Molecular and serologic analysis in the transmission of the GB hepatitis agents. Journal of Medical Virology 46:81-90.
24. Schlauder GG, Pilot-Matias TJ, Gabriel GS, Simons JN, Muerhoff AS, Dawson GJ, Mushahwar IK (1995b): Origin of GB-hepatitis viruses. Lancet 346:447.
25. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Buijk SL, Chalmers ML, Van Sant CL, Mushahwar IK (1995a): Identification of two flavivirus-like genomes in the GB hepatitis agent. Proceedings of the National Academy of Sciences USA 92:3401-3405.
26. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK (1995b): Isolation of novel virus-like sequences associated with human hepatitis. Nature Medicine 1:564-569.
27. Swinscow TDV (1982): "Statistics at Square One. London British Medical Association Publishers, pp 43-54, 54-57.
28. Tassopoulos NC, Hatzakis A, Kuhns M, Miriagou V, Delladetsima I, Koutelou MG, Toulomi G, Paptheodoridis GV, Chrispeels J, Troonen H, Trichopoulos D (1994): Clinical and laboratory features of acute community acquired non-A, non-B non-C hepatitis. In Nishioka K, Suzuki H, Mishiro S, Oda T (eds): "Viral Hepatitis and Liver Disease." pp 80-84.
29. Thiers V, Lunel F, Valla D, Azar N, Fretz C, Frangeul L, Huraux J-M, Opolon P, Brechot C (1993): Post-transfusional anti-HCV-negative non-A non-B hepatitis (II): Serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses. Journal of Hepatology 18:34-39.
30. Yoshiba M, Okamoto H, Mishiro S (1995): Contribution of hepatitis C virus to non-A, nonB fulminant hepatitis in Japan. Lancet 346:1131-1132.
31. Zanotto PM de A, Gould EA, Gao GF, Harvey PH, Holmes EC (1996): Population dynamics of flaviviruses revealed by molecular phylogenies. Proceedings of the National Academy of Sciences USA 93:548-553.
32. Zuckerman AJ (1996): Alphabet of hepatitis viruses. Lancet 347: 558-559.